Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13957 | 738 | 40.6 | 76% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1608 | 6531 | DOLASTATIN 10//DIDEMNIN B//CYCLOLINOPEPTIDE A |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DOLASTATIN 10 | Author keyword | 59 | 84% | 4% | 32 |
2 | DIDEMNIN B | Author keyword | 58 | 88% | 4% | 28 |
3 | TZT 1027 | Author keyword | 50 | 86% | 3% | 25 |
4 | CRYPTOPHYCINS | Author keyword | 33 | 100% | 2% | 13 |
5 | PLITIDEPSIN | Author keyword | 31 | 82% | 2% | 18 |
6 | APLIDIN | Author keyword | 29 | 88% | 2% | 14 |
7 | APLIDINE | Author keyword | 25 | 77% | 2% | 17 |
8 | DOLASTATIN | Author keyword | 25 | 77% | 2% | 17 |
9 | KAHALALIDE F | Author keyword | 17 | 68% | 2% | 15 |
10 | CRYPTOPHYCIN | Author keyword | 15 | 67% | 2% | 14 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DOLASTATIN 10 | 59 | 84% | 4% | 32 | Search DOLASTATIN+10 | Search DOLASTATIN+10 |
2 | DIDEMNIN B | 58 | 88% | 4% | 28 | Search DIDEMNIN+B | Search DIDEMNIN+B |
3 | TZT 1027 | 50 | 86% | 3% | 25 | Search TZT+1027 | Search TZT+1027 |
4 | CRYPTOPHYCINS | 33 | 100% | 2% | 13 | Search CRYPTOPHYCINS | Search CRYPTOPHYCINS |
5 | PLITIDEPSIN | 31 | 82% | 2% | 18 | Search PLITIDEPSIN | Search PLITIDEPSIN |
6 | APLIDIN | 29 | 88% | 2% | 14 | Search APLIDIN | Search APLIDIN |
7 | APLIDINE | 25 | 77% | 2% | 17 | Search APLIDINE | Search APLIDINE |
8 | DOLASTATIN | 25 | 77% | 2% | 17 | Search DOLASTATIN | Search DOLASTATIN |
9 | KAHALALIDE F | 17 | 68% | 2% | 15 | Search KAHALALIDE+F | Search KAHALALIDE+F |
10 | CRYPTOPHYCIN | 15 | 67% | 2% | 14 | Search CRYPTOPHYCIN | Search CRYPTOPHYCIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SPONGE DYSIDEA ARENARIA | 121 | 97% | 5% | 34 |
2 | POTENT CYTOTOXIC DEPSIPEPTIDE | 103 | 97% | 4% | 30 |
3 | DEHYDRODIDEMNIN B | 85 | 100% | 4% | 26 |
4 | ANTIMICROTUBULE AGENT | 80 | 84% | 6% | 43 |
5 | ARENASTATIN A | 79 | 87% | 5% | 39 |
6 | SP STRAIN GSV 224 | 56 | 75% | 6% | 41 |
7 | IMMUNOSUPPRESSIVE CYCLIC PEPTIDE | 55 | 92% | 3% | 22 |
8 | DIDEMNIN B | 42 | 61% | 6% | 44 |
9 | ANTIPROLIFERATIVE AGENT DIDEMNIN | 32 | 85% | 2% | 17 |
10 | BRYOPSIS SP | 29 | 77% | 3% | 20 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Drug development from marine natural products | 2009 | 337 | 251 | 45% |
Didemnins, tamandarins and related natural products | 2012 | 24 | 97 | 84% |
Marine natural products as anticancer drugs | 2005 | 229 | 58 | 43% |
Marine natural products and related compounds in clinical and advanced preclinical trials | 2004 | 359 | 229 | 26% |
The odyssey of marine pharmaceuticals: a current pipeline perspective | 2010 | 139 | 77 | 18% |
Natural products as probes of cell biology: 20 years of didemnin research | 2002 | 76 | 117 | 77% |
Chemistry and Biology of Kahalalides | 2011 | 16 | 61 | 64% |
Bioactive Peptides and Depsipeptides with Anticancer Potential: Sources from Marine Animals | 2012 | 28 | 108 | 32% |
Aplidine: A paradigm of how to handle the activity and toxicity of a novel marine anticancer poison | 2007 | 27 | 128 | 49% |
Recent approaches for the synthesis of modified cryptophycins | 2013 | 4 | 67 | 84% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POLIGONO IND LA MINA | 3 | 57% | 0.5% | 4 |
2 | SOCIEDAD UNIPERSONAL | 3 | 100% | 0.4% | 3 |
3 | COLMENAR VIEJO | 3 | 42% | 0.7% | 5 |
4 | PHARMA MAR | 2 | 67% | 0.3% | 2 |
5 | NDDO | 2 | 50% | 0.4% | 3 |
6 | CANC CANC CHEMOTHER Y TOSHIMA KU | 1 | 100% | 0.3% | 2 |
7 | MECANISMES MOL COMMUN CELLULAI | 1 | 50% | 0.3% | 2 |
8 | SOC UNIPERSONAL | 1 | 100% | 0.3% | 2 |
9 | EQUIPE PROD NAT SYNTH CHIM MED PNSCM | 1 | 40% | 0.3% | 2 |
10 | RD ADM | 1 | 27% | 0.4% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000170614 | LYNGBYA MAJUSCULA//AERUGINOSIN//HAPALOSIPHON SP |
2 | 0.0000165001 | BRYOSTATIN 1//BRYOSTATIN//BRYOSTATINS |
3 | 0.0000153937 | SANSALVAMIDE A//URUKTHAPELSTATIN A//PL EXPT GENOM |
4 | 0.0000138936 | RICE FALSE SMUT//USTILAGINOIDEA VIRENS//RHIZOXIN |
5 | 0.0000125894 | JASPAMIDE//BENGAMIDES//JASPIS SP |
6 | 0.0000112867 | APLYRONINE A//THEONELLA SWINHOEI//BISTRAMIDE A |
7 | 0.0000108071 | TRABECTEDIN//ET 743//YONDELIS |
8 | 0.0000104991 | COMBRETASTATIN//COMBRETASTATIN A 4//COMBRETASTATINS |
9 | 0.0000095202 | ERIBULIN MESYLATE//ERIBULIN//HALICHONDRIN B |
10 | 0.0000085677 | PREUSSIN//HAPALOSIN//ALPHA AMINO ALDEHYDES |